Maryland Settles EpiPen Claims Against Mylan, Inc.
On May 4, 2026, Maryland’s Attorney General announced that the Antitrust Division reached a settlement with Mylan Inc. (Mylan), the company that sells the EpiPen®, resolving concerns about anticompetitive conduct involving the cost, marketing, and availability of EpiPen products. The Ep[...]